MyChesCo on MSN4 个月
New Study Highlights XHANCE’s Efficacy in Treating Chronic Rhinosinusitis
YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced the publication of a paper in the International Forum of Allergy & ...